BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25978814)

  • 1. Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.
    Crompot E; Van Damme M; Duvillier H; Pieters K; Vermeesch M; Perez-Morga D; Meuleman N; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
    PLoS One; 2015; 10(5):e0127209. PubMed ID: 25978814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotype controls in phenotyping and quantification of microparticles: a major source of error and how to evade it.
    Trummer A; De Rop C; Tiede A; Ganser A; Eisert R
    Thromb Res; 2008; 122(5):691-700. PubMed ID: 18304614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles.
    Yuana Y; Oosterkamp TH; Bahatyrova S; Ashcroft B; Garcia Rodriguez P; Bertina RM; Osanto S
    J Thromb Haemost; 2010 Feb; 8(2):315-23. PubMed ID: 19840362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD.
    Tőkés-Füzesi M; Ruzsics I; Rideg O; Kustán P; Kovács GL; Molnár T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3749-3757. PubMed ID: 30532530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
    Front Immunol; 2018; 9():322. PubMed ID: 29545790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
    Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
    Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
    Christersson C; Lindahl B; Siegbahn A
    Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
    Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
    J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease.
    Viñuela-Berni V; Doníz-Padilla L; Figueroa-Vega N; Portillo-Salazar H; Abud-Mendoza C; Baranda L; González-Amaro R
    Clin Exp Immunol; 2015 Jun; 180(3):442-51. PubMed ID: 25639560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
    Aass HC; Øvstebø R; Trøseid AM; Kierulf P; Berg JP; Henriksson CE
    Cytometry A; 2011 Dec; 79(12):990-9. PubMed ID: 21990118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles and Kawasaki disease: a marker of vascular damage?
    Guiducci S; Ricci L; Romano E; Ceccarelli C; Distler JH; Miniati I; Calabri GB; Distler O; Matucci Cerinic M; Falcini F
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S121-5. PubMed ID: 21385556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry.
    Erdbrügger U; Rudy CK; Etter ME; Dryden KA; Yeager M; Klibanov AL; Lannigan J
    Cytometry A; 2014 Sep; 85(9):756-70. PubMed ID: 24903900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicolor flow cytometric assay for measurement of platelet-derived microparticles.
    Mobarrez F; Antovic J; Egberg N; Hansson M; Jörneskog G; Hultenby K; Wallén H
    Thromb Res; 2010 Mar; 125(3):e110-6. PubMed ID: 19939440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer.
    Perez-Pujol S; Marker PH; Key NS
    Cytometry A; 2007 Jan; 71(1):38-45. PubMed ID: 17216623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
    Ayers L; Kohler M; Harrison P; Sargent I; Dragovic R; Schaap M; Nieuwland R; Brooks SA; Ferry B
    Thromb Res; 2011 Apr; 127(4):370-7. PubMed ID: 21257195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.